Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.19%, DAX +0.29%, CAC40 +0.27%

Sep 05 ,2025

  • Synopsis

    • European equity markets are set to open in positive territory, amidst Asian equities trading higher Friday. Recovery of Greater China markets being led by mainland stocks. Japan and Taiwan indexes outperforming with Korea flat and Australia logging mild gain. S&P 500 futures up slightly afterhours.

    • On today's agenda, Chancellor Merz set to attend the inauguration of the first European exascale supercomputer, called "Jupiter". In the UK, Reform UK, led by Nigel Farage, holds its annual conf (through Sat).

    • In trade developments, President Trump signed executive order implementing US-Japan trade agreement, formally establishing 15% tariff that also extends to autos and avoids tariff stacking. Japan to increase share of US rice imports under existing quota system to 75% and commit to annual agricultural purchases totalling A$8B.

    • Later Friday US nonfarm payrolls forecast to show another sub-100K headline print and unemployment rate nudging up to highest since Jul-2023. Weak July payrolls data and dovish-leaning remarks from Fed Chair Powell had already led markets to fully price in September rate cut with another reduction expected by year-end.

    • In central banks, Bundesbank's Köhler-Geib panellist at 13:15CET at State of Hesse's representative office in Brussels. Latvia central bank's Kazāka holds regular meeting with President Rinkēvičs.

    • European macro data releases due today include, UK Jul retail sales, Aug house price index - Halifax, Germany Jul factory orders, France Jul trade balance, Italy Jul retail sales, Norway Jul manufacturing production, Switzerland Aug consumer confidence - SECO, Eurozone Q3 final GDP, Austria Q2 final GDP, Ireland Q2 final GDP, Greece Q2 GDP

    • In corporate news, yesterday after the market closed, Sofina (SOF.BB) reported H1 earnings, whilst OSE Immunotherapeutics (OSE.FP) issued a presentation for its strategy for 2025-2028 ahead of the 30-Sept AGM. Elsewhere, Ørsted (ORSTED.DC) announced adjustment to full-year EBITDA guidance for 2025 following lower-than-normal offshore wind speeds during July and August. In other corporate developments, Temenos AG (TEMN.SW) announced that Jean-Pierre Brulard will be stepping down from the role of CEO, effective immediately. The board has appointed Takis Spiliopoulos, the company's CFO, as Interim CEO while the search for a permanent successor is underway.

    • In M&A, Hexagon AB (HEXA.B.SS) announced that it has entered into a definitive agreement to sell its Design & Engineering business, which includes the business formerly known as MSC Software, to Cadence Design Systems, Inc. for €2.7B. In France, the FT reported that Safran (SAF.FP) is weighing the sale of a large portion of its aircraft interiors business.

  • Politics/Macro/World News

    • Rayner's political future hangs in balance as ethics report expected as early as today - BBC

    • Oil Set for Weekly Loss as Tension Builds Ahead of OPEC+ Meeting - Bloomberg

    • Political Paralysis Threatens Poland's $1 Trillion Economy - Bloomberg

    • 26 nations vow to give Ukraine postwar security guarantees, Macron says - Reuters

    • Uranium shortfall threatens nuclear energy renaissance, industry warned - FT

  • Top company news

    • Earnings/updates

      • HEXA.B.SS (Hexagon) -- agrees to sale of Design & Engineering business to Cadence for €2.7B

      • SOF.BB (Sofina) -- reports H1 EPS (€11.54) vs year-ago €16.25

      • OSE.FP (OSE Immunotherapeutics) -- presents Strategy 2025-2028 ahead of 30-Sept AGM

      • EXM.BB (Exmar NV) -- reports H1 IFRS EPS $0.77 vs year-ago $1.21

      • LIN.FP (Linedata Services) -- reports H1 net income €8M vs year-ago €10.6M

      • BNOR.NO (BlueNord) -- reports preliminary August net production 37.2 mboepd

      • VIL.FP (Viel & Cie) -- reports H1 net income €69.2M vs year-ago €65.4M

      • BELYS.BB (Belysse Group) -- reports H1 adjusted EBITDA €17.3M vs year-ago €21.5M

      • ORSTED.DC (Ørsted) -- adjusts full-year EBITDA guidance for 2025 following lower-than-normal offshore wind speeds during July and August

      • Aldo sue to report today includes:

        • Earnings:

          • UK: Ashmore Group (ASHM.LN), Camellia (CAM.LN)

        • Sales/Traffic: Finnair (FIA1S.FH)

    • M&A

      • CDNS (Cadence Design Systems) -- to acquire Hexagon's design & engineering business

      • SAF.FP (Safran) -- weighing sale of large portion of aircraft interiors business - FT

      • SBUX (Starbucks) -- Bids for Starbucks' China operations value the business at up to $5B - Reuters

      • BBVA.SM (Banco Bilbao Vizcaya Argentaria) -- discloses the US SEC has granted relief to BBVA around Banco de Sabadell deal

      • HEXA.B.SS (Hexagon) -- agrees to sale of Design & Engineering business to Cadence for €2.7B

      • DTG.GR (Daimler Truck Holding) -- Daimler Truck seeking partner for autonomous-driving unit Torc Robotics to help fund investment needs - Bloomberg (4-Sep, 14:37 CET)

      • EOAN.GR (E.ON SE) -- E.ON sells gas distribution network in the Czech Republic to CEZ Group; price not disclosed

      • PRIO, Brava Energia and BW Energy exploring acquisition of Petronas' stake in Brazil's Tartaruga oil field - Bloomberg

      • Tether has held talks about investing in gold mining - FT

    • Healthcare

      • ROG.SW (Roche Holding) -- Roche receives CE IVDR approval for label expansions for VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx assay

      • ROG.SW (Roche Holding) -- Genentech presents new data from AVONELLE-X, SALWEEN studies of Vabysmo at 25th Euretina Congress

      • BICO.SS (BICO Group) -- BICO Group's Biosero to develop integrated lab automation solutions for a global pharma company to a value of $15.2M (~SEK143.8M)

    • Other

      • DGE.LN (Diageo) -- Transcript Intelligence: Diageo at Barclays Global Consumer Staples Conference

      • TTE.FP (TotalEnergies) -- Transcript Intelligence: TotalEnergies at Barclays CEO Energy Power Conference

      • ML.FP (Cie Generale des Etablissements Michelin SA) -- Michelin publishes global tire market data for July

      • RHM.GR (Rheinmetall) -- Transcript Intelligence: Rheinmetall at Gabelli Funds Aerospace & Defense Symposium

      • FR.FP (Valeo SE) -- Valeo and Capgemini collaborate on testing and validating new Advanced Driver Assistance System

      • BAB.LN (Babcock International Group) -- Transcript Intelligence: Babcock International Group Business Update Call

      • OMV.AV (OMV) -- could cut up to 2,000 jobs as part of savings program - Kurier

      • STB.NO (Storebrand) -- CFO Lars Aa. Løddesøl to step down; appoints Kjetil R. Krøkje as new CFO

      • NOD.NO (Nordic Semiconductor) -- completes NOK1.05B (~$100M) private placement at NOK150/sh

      • 4DS Memory to initiate strategic review; terminates agreement with Infineon Technologies, and announces management changes

      • Regional Gaming Revenues - New York Sports Betting August 2025

  • Key rating changes

    • Upgrades

      • ASML.NA (ASML Holding) -- to buy from neutral at UBS

      • STMPA.FP (STMicroelectronics) -- to outperform from neutral at BNP Paribas Exane

      • SRT3.GR (Sartorius) -- to buy from hold at Stifel

      • SGSN.SW (SGS) -- to outperform from neutral at BNP Paribas Exane

      • KRX.ID (Kingspan Group) -- to market perform from underperform at Bernstein

    • Downgrades

      • ADM.LN (Admiral Group) -- to sell from reduce at Peel Hunt

      • DKSH.SW (DKSH Holding) -- to underperform from outperform at BNP Paribas Exane

    • Initiations

      • (N91.LN) Ninety One Plc -- buy at SBG Securities

    • Other Actions

      • HFG.GR (HelloFresh) -- resumed hold at Stifel; prior rating was hold

      • G.IM (Assicurazioni Generali) -- reinstated outperform at Mediobanca

  • Data

    • Nikkei +0.88% to 42954.41

    • Hang Seng +0.83% to 25266.14

    • Shanghai Composite +0.43% to 3781.92

    • S&P futures +15.8 vs prior close of 6510.8

    • €-$ +0.0022 or +0.19% to 1.1673

    • $-¥ (0.29) or (0.19%) to 148.20

    • €-¥ (0.02) or (0.01%) to 172.96

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE